Stratasys (SSYS) Q3 2025 earnings summary

Executive summary

• Delivered solid operating cash flow and positive adjusted EPS in Q3 2025, driven by disciplined cost management and operational excellence amid macro-driven capital equipment spending constraints.

• Focused on operational excellence, customer partnerships, and advancing additive manufacturing adoption in high-value verticals such as aerospace, defense, automotive, dental, and medical modeling.

• Strategic wins and partnerships in aerospace (Boeing, Embraer), defense (Honeywell, TE Connectivity, L3Harris), Andretti Global in automotive, and a major U.S. tech company for FDM/F3300 systems.

• Expansion into dental and pharmaceutical verticals, with new leadership, product launches, and removal of toxic chemicals from resins.

• Recurring revenue stability and infrastructure investments provide a foundation for future growth.

Financial highlights

• Q3 2025 consolidated revenue was $137 million, down 2.1% year-over-year; product revenue flat at $94.1 million, service revenue $42.9 million (down from $45.9 million).

• System revenue rose to $32.1 million (from $31.7 million), consumables revenue stable at $62 million.

• GAAP gross margin declined to 41% (from 44.8%), non-GAAP gross margin to 45.3% (from 49.6%), mainly due to increased tariffs and product mix.

• GAAP net loss was $55.6 million (or $0.65/share), including a $33.9 million non-cash impairment; non-GAAP net income was $1.5 million (or $0.02/share).

• Adjusted EBITDA was $5 million; operating cash flow was $6.9 million, up from a $4.5 million outflow last year.

• Ended Q3 with $255 million in cash and no debt.

Outlook and guidance

• Reaffirmed 2025 non-GAAP guidance: revenue $550–560 million, non-GAAP gross margin 46.7–47%, non-GAAP operating margin 1.5–2%.

• Adjusted EPS expected at $0.13–0.16; adjusted EBITDA $30–32 million.

• Full-year operating cash flow expected to grow year-over-year.

• Price increases implemented in Q3 to offset tariffs, with full impact expected in Q4 and further margin improvement anticipated into 2026.

• Capital expenditures for 2025 expected to be $20–25 million.